FDA Inspection 816428 — Pace Analytical Life Sciences

Pace Analytical Life Sciences — FEI 3006500621

The FDA completed an inspection of Pace Analytical Life Sciences on Jan 10, 2013 in Salem, NH. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 5 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 10, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Salem, NH (United States)

Citations

IDCFRDescription
117421 CFR 211.42(b)Product flow through building is inadequate
121521 CFR 211.67(b)Written procedures not established/followed
127421 CFR 211.68(a)Calibration/Inspection/Checking not done
202721 CFR 211.192Investigations of discrepancies, failures
354721 CFR 211.46(b)Equipment for Environmental Control

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.